SARS-CoV-2阳性与阴性孕妇不良妊娠结局的系统综述与荟萃分析
该系统综述与荟萃分析比较了入院分娩时SARS-CoV-2检测阳性与阴性孕妇的妊娠结局,共纳入6项研究、728例阳性与3836例阴性分娩。结果显示,阳性与阴性组的宫内胎儿死亡、新生儿死亡、早产及孕产妇死亡发生率均无显著差异。
要点
- SARS-CoV-2阳性与阴性孕妇的宫内胎儿死亡发生率均为1.1%(P=.60)。
- 阳性组新生儿死亡0.0%,阴性组0.2%(P=.90),无显著差异。
- 早产与孕产妇死亡发生率在两组间亦无显著差异。
核心结论
- 入院分娩时SARS-CoV-2检测阳性的孕妇,其宫内胎儿死亡和新生儿死亡发生率与检测阴性者相似。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Ovid、EMBASE、CINAHL和Cochrane Library自建库至2020年7月17日,并手检至2020年9月24日。
- 纳入标准为同时比较至少20例入院分娩时SARS-CoV-2阳性与阴性孕妇的出版物,最终纳入6项研究。
- 分析纳入728例阳性孕妇的分娩和3836例同期阴性孕妇的分娩。
主要发现
- 宫内胎儿死亡(妊娠20周或以后)在阳性组发生8/728(1.1%),阴性组44/3836(1.1%),P=.60。
- 新生儿死亡在阳性组发生0/432(0.0%),阴性组5/2400(0.2%),P=.90。
- 早产在阳性组发生95/714(13.3%),阴性组446/3759(11.9%),P=.31。
- 孕产妇死亡在阳性组发生3/559(0.5%),阴性组8/3155(0.3%),P=.23。
临床怎么用
- 对于入院分娩时SARS-CoV-2检测阳性的孕妇,宫内胎儿死亡和新生儿死亡风险与阴性者相似,可据此进行围产期咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the risk of intrauterine fetal death (20 weeks of gestation or later) and neonatal death among individuals who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared with those who tested negative for SARS-CoV-2 on admission for delivery. DATA SOURCES: MEDLINE, Ovid, EMBASE, Cumulative Index to Nursing and Allied Health, and Cochrane Library were searched from their inception until July 17, 2020. Hand search for additional articles continued through September 24, 2020. ClinicalTrials.gov was searched on October 21, 2020. METHODS OF STUDY SELECTION: The inclusion criteria were publications that compared at least 20 cases of both pregnant patients who tested positive for SARS-CoV-2 on admission to labor and delivery and those who tested negative. Exclusion criteria were publications with fewer than 20 individuals in either category or those lacking data on primary outcomes. A systematic search of the selected databases was performed, with co-primary outcomes being rates of intrauterine fetal death and neonatal death. Secondary outcomes included rates of maternal and neonatal adverse outcomes. TABULATION, INTEGRATION, AND RESULTS: Of the 941 articles and completed trials identified, six studies met criteria. Our analysis included 728 deliveries to patients who tested positive for SARS-CoV-2 and 3,836 contemporaneous deliveries to patients who tested negative. Intrauterine fetal death occurred in 8 of 728 (1.1%) patients who tested positive and 44 of 3,836 (1.1%) who tested negative (P=.60). Neonatal death occurred in 0 of 432 (0.0%) patients who tested positive and 5 of 2,400 (0.2%) who tested negative (P=.90). Preterm birth occurred in 95 of 714 (13.3%) patients who tested positive and 446 of 3,759 (11.9%) who tested negative (P=.31). Maternal death occurred in 3 of 559 (0.5%) patients who tested positive and 8 of 3,155 (0.3%) who tested negative (P=.23). CONCLUSION: The incidences of intrauterine fetal death and neonatal death were similar among individuals who tested positive compared with negative for SARS-CoV-2 when admitted to labor and delivery. Other immediate outcomes of the newborns were also similar among those born to individuals who tested positive compared with negative for SARS-CoV-2. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020203475.
引用
- Huntley BJF, Mulder IA, Di Mascio D, et al. Adverse Pregnancy Outcomes Among Individuals With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review and Meta-analysis. Obstet Gynecol. 2021. PMID: 33706357. doi:10.1097/AOG.0000000000004320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。